GlaxoSmithKline PLC (GSK.N)
16 Oct 2017
Canadian health regulators have approved GlaxoSmithKline's key shingles vaccine, the company said on Friday.
Oct 13 Canadian health regulators have approved GlaxoSmithKline's key shingles vaccine, the company said on Friday.
* SHINGRIX HAS BEEN APPROVED IN CANADA FOR PREVENTION OF SHINGLES (HERPES ZOSTER) IN PEOPLE AGED 50 YEARS OR OLDER
LONDON (Reuters Breakingviews) - Painkillers and pile cream: these are either the recipe for a terrible night in, or a potentially good corporate deal. Pfizer, the $215 billion U.S. drugmaker, has tasked investment banks with looking into a spinoff or sale of its consumer-goods division, which makes Advil and Preparation H. New GlaxoSmithKline boss Emma Walmsley would be well placed to offer a home.
LONDON, Oct 9 Prime Minister Theresa May told business leaders on Monday that they could be certain there would be a two-year transition period after Britain's exit from the European Union, a source told Reuters.
LONDON Britain's pharmaceuticals industry has thrown in the towel in a legal battle over new cost curbs imposed by the state-run health service, after failing to secure a judicial review.
LONDON, Oct 5 Britain's pharmaceuticals industry has thrown in the towel in a legal battle over new cost curbs imposed by the state-run health service, after failing to secure a judicial review.
LONDON, Oct 4 Britain's pharmaceuticals industry failed to secure a judicial review of new cost curbs, which mean drugs costing NHS England more than 20 million pounds ($26 mln) annually no longer get automatic funding.
BRIEF-GlaxoSmithKline receives approval for Benlysta in Japan for treatment of systemic lupus erythematosus
* JAPANESE MHLW APPROVED BENLYSTA FOR TREATMENT OF ADULT PATIENTS WITH SLE WHO ARE INADEQUATE RESPONDERS TO EXISTING THERAPIES Further company coverage:
The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Friday.
|Takeda Pharmaceutical Co Ltd (4502.T)||¥6,225||+13.00|
|Procter & Gamble Co (PG.N)||$93.14||+0.10|
|Johnson & Johnson (JNJ.N)||$136.12||-0.31|
|Pfizer Inc. (PFE.N)||$35.98||-0.36|
|Novartis AG (NOVN.S)||CHF84.50||--|
|Unilever NV (UNc.AS)||€51.75||--|
|Unilever NV (UNIA.AS)||€51.75||--|
|Unilever NV (UN_pa.AS)||€957.24||--|
|Unilever NV (UN_p.AS)||€303.15||--|
|Unilever NV (UN_pb.AS)||--||--|